The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
- PMID: 28331856
- PMCID: PMC5346368
- DOI: 10.1155/2017/2748614
The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
Abstract
The identification of permissible HLA class II mismatches can prevent DSA in mismatched transplantation. The HLA-DR phenotype of recipients contributes to DSA formation by presenting allo-HLA-derived peptides to T-helper cells, which induces the differentiation of B cells into plasma cells. Comparing the binding affinity of self and nonself allo-HLA-derived peptides for recipients' HLA class II antigens may distinguish immunogenic HLA mismatches from nonimmunogenic ones. The binding affinities of allo-HLA-derived peptides to recipients' HLA-DR and HLA-DQ antigens were predicted using the NetMHCIIpan 3.1 server. HLA class II mismatches were classified based on whether they induced DSA and whether self or nonself peptide was predicted to bind with highest affinity to recipients' HLA-DR and HLA-DQ. Other mismatch characteristics (eplet, hydrophobic, electrostatic, and amino acid mismatch scores and PIRCHE-II) were evaluated. A significant association occurred between DSA formation and the predicted HLA-DR presentation of nonself peptides (P = 0.0169; accuracy = 80%; sensitivity = 88%; specificity = 63%). In contrast, mismatch characteristics did not differ significantly between mismatches that induced DSA and the ones that did not, except for PIRCHE-II (P = 0.0094). This methodology predicts DSA formation based on HLA mismatches and recipients' HLA-DR phenotype and may identify permissible HLA mismatches to help optimize HLA matching and guide donor selection.
Conflict of interest statement
The author declares that there is no conflict of interests regarding the publication of this paper.
Figures


Similar articles
-
Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study.Front Immunol. 2020 Aug 27;11:2000. doi: 10.3389/fimmu.2020.02000. eCollection 2020. Front Immunol. 2020. PMID: 32973806 Free PMC article.
-
Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study.J Am Soc Nephrol. 2020 Sep;31(9):2193-2204. doi: 10.1681/ASN.2020010019. Epub 2020 Aug 6. J Am Soc Nephrol. 2020. PMID: 32764139 Free PMC article.
-
Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.Transplant Proc. 2018 Oct;50(8):2388-2391. doi: 10.1016/j.transproceed.2018.02.183. Epub 2018 Mar 20. Transplant Proc. 2018. PMID: 30316363
-
Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.Hum Immunol. 2016 Nov;77(11):1092-1100. doi: 10.1016/j.humimm.2016.04.003. Epub 2016 Apr 6. Hum Immunol. 2016. PMID: 27060781 Review.
-
Human leukocyte antigen matching in organ transplantation: what we know and how can we make it better (Revisiting the past, improving the future).Curr Opin Organ Transplant. 2018 Aug;23(4):470-476. doi: 10.1097/MOT.0000000000000538. Curr Opin Organ Transplant. 2018. PMID: 29750676 Review.
Cited by
-
Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk - a retrospective analysis of UNOS database.Ann Med. 2023 Dec;55(1):2215536. doi: 10.1080/07853890.2023.2215536. Ann Med. 2023. PMID: 37232582 Free PMC article.
-
Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation.Front Immunol. 2021 Jun 11;12:687715. doi: 10.3389/fimmu.2021.687715. eCollection 2021. Front Immunol. 2021. PMID: 34177940 Free PMC article.
-
Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.Clin Exp Immunol. 2021 Feb;203(2):315-328. doi: 10.1111/cei.13533. Epub 2020 Oct 29. Clin Exp Immunol. 2021. PMID: 33025622 Free PMC article.
-
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development.Antibodies (Basel). 2024 Jul 24;13(3):61. doi: 10.3390/antib13030061. Antibodies (Basel). 2024. PMID: 39189232 Free PMC article. Review.
-
Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.JAMA Dermatol. 2019 Mar 1;155(3):307-314. doi: 10.1001/jamadermatol.2018.4983. JAMA Dermatol. 2019. PMID: 30673077 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials